FDA Inspection 1047497 — Sebastian Grosicki, M.D.
The FDA completed an inspection of Sebastian Grosicki, M.D. on Feb 22, 2018 in Chorzow. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 22, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chorzow (Poland)
Additional Details
Clinical Investigator (CI)